High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population‐based study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population‐based study

Published:2020-06-09 Issue:4 Volume:190 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Larsson Karin¹²^ORCID,Mattsson Mattias²³^ORCID,Ebrahim Fereshte⁴^ORCID,Glimelius Ingrid²³^ORCID,Höglund Martin¹²^ORCID

Affiliation:

1. Institute of Medical Sciences Uppsala University Uppsala Sweden

2. Deptartment of Blood and Tumour Diseases Uppsala University Hospital Uppsala Sweden

3. Institute of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden

4. Regional Cancer Centre Stockholm‐Gotland Stockholm City Council Stockholm Sweden

Funder

Swedish CLL group

Uppsala U-CAN biobank

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16859

Reference13 articles.

1. Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population‐based study

2. Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

3. Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study

4. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

5. Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Lymphocytic Leukemia: Time to Care for the Survivors;Journal of Clinical Oncology;2024-06-10

2. Long-Term Risks of Cardiovascular Death among Older Patients with Major Hematological Malignancies: A Population-Based Cohort Study from SEER Database;Cancer Epidemiology, Biomarkers & Prevention;2024-05-07

3. Cardiovascular side effects of signaling pathway inhibitors in chronic lymphocytic leukemia therapy;Onkologie;2023-11-29

4. Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib—A retrospective analysis on consecutive patients from a well‐defined region;European Journal of Haematology;2023-08-10

5. Unlocking the Potential of Immunotherapy in Cardiovascular Disease: A Comprehensive Review of Applications and Future Directions;Cureus;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3